Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis

Front Med. 2021 Oct;15(5):649-656. doi: 10.1007/s11684-021-0830-0. Epub 2021 May 11.

Abstract

Tumorigenesis involves metabolic reprogramming and abnormal lipid metabolism, which is manifested by increased endogenous fat mobilization, hypertriglyceridemia, and increased fatty acid synthesis. Fatty acid synthase (FASN) is a key enzyme for the de novo synthesis of fatty acids, and monoacylglycerol esterase (MGLL) is an important metabolic enzyme that converts triglycerides into free fatty acids. Both enzymes play an important role in lipid metabolism and are associated with tumor-related signaling pathways, the most common of which is the PI3K-AKT signaling pathway. They can also regulate the immune microenvironment, participate in epithelial-mesenchymal transition, and then regulate tumor invasion and metastasis. Current literature have shown that these two genes are abnormally expressed in many types of tumors and are highly correlated with tumor migration and invasion. This article introduces the structures and functions of FASN and MGLL, their relationship with abnormal lipid metabolism, and the mechanism of the regulation of tumor invasion and metastasis and reviews the research progress of the relationship of FASN and MGLL with tumor invasion and metastasis.

Keywords: FASN; MGLL; lipid metabolism; metastasis; tumor invasion.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Fatty Acid Synthase, Type I* / genetics
  • Fatty Acid Synthase, Type I* / metabolism
  • Humans
  • Lipid Metabolism
  • Monoacylglycerol Lipases / metabolism*
  • Neoplasms*
  • Phosphatidylinositol 3-Kinases
  • Signal Transduction
  • Tumor Microenvironment

Substances

  • FASN protein, human
  • Fatty Acid Synthase, Type I
  • MGLL protein, human
  • Monoacylglycerol Lipases